The Humanized Mouse Model: What Added Value Does It Offer for HIV Research?
Pathogens · 17.04.2023 · 12 (4) · 608
DOI: 10.3390/pathogens12040608 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 17.04.2023. Verfasst von Luca Baroncini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, 8091 Zurich, Switzerland. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
In the early 2000s, novel humanized mouse models based on the transplantation of human hematopoietic stem and progenitor cells (HSPCs) into immunocompromised mice were introduced (hu mice). The human HSPCs gave rise to a lymphoid system of human origin. The HIV research community has greatly benefitted from these hu mice. Since human immunodeficiency virus (HIV) type 1 infection results in a high-titer disseminated HIV infection, hu mice have been of great value for all types of HIV research from pathogenesis to novel therapies. Since the first description of this new generation of hu mice, great efforts have been expended to improve humanization by creating other immunodeficient mouse models or supplementing mice with human transgenes to improve human engraftment. Many labs have their own customized hu mouse models, making comparisons quite difficult. Here, we discuss the different hu mouse models in the context of specific research questions in order to define which characteristics should be considered when determining which hu mouse model is appropriate for the question posed. We strongly believe that researchers must first define their research question and then determine whether a hu mouse model exists, allowing the research question to be studied.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, 8091 Zurich, Switzerland.
Förderung
- Swiss National Science Foundation
Zitieren
APA
Baroncini, L., Bredl, S., Nicole, K. P., & Speck, R. F. (2023). The Humanized Mouse Model: What Added Value Does It Offer for HIV Research?. Pathogens, 12(4), 608. https://doi.org/10.3390/pathogens12040608
Vancouver
Baroncini L, Bredl S, Nicole KP, Speck RF. The Humanized Mouse Model: What Added Value Does It Offer for HIV Research?. Pathogens. 2023;12(4):608. doi:10.3390/pathogens12040608
BibTeX
@article{Baroncini2023,
author = {Baroncini, Luca and Bredl, Simon and Nicole, Kadzioch P and Speck, Roberto F},
title = {The Humanized Mouse Model: What Added Value Does It Offer for HIV Research?},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {4},
pages = {608},
doi = {10.3390/pathogens12040608}
}
EUVIMED